韦氏三联九针联合益气明目汤治疗高原地区非增殖性糖尿病视网膜病变的疗效观察OA
Observation on the Therapeutic Efficacy of WEI's Triple NineNeedles Technique Combined with Yiqi Mingmu Decoc-tion in Treating Non-proliferative Diabetic Retinopathy in High-altitude Regions
目的 观察韦氏三联九针联合中药治疗高原地区非增殖性糖尿病视网膜病变(NPDR)的临床疗效.方法 纳入2023年9月—2024年9月青海省中医院诊治的NPDR患者120例(120只眼),中医辨证为气阴两虚证.随机分为西药组(A组)、针刺组(B组)、中药组(C组)、针刺+中药组(D组),均纳入右眼.最终纳入A组27例(27只眼),B组24例(24只眼),C组30例(30只眼),D组23例(23只眼).A组予羟苯磺酸钙胶囊口服,B组在A组基础上联合韦氏三联九针治疗,C组在A组的基础上联合益气明目汤口服,D组在A组的基础上联合韦氏三联九针+益气明目汤治疗.4组均治疗12周.分别于治疗前和治疗后检测受试者最佳矫正视力(BCVA),视野平均光敏感度(MS),黄斑中心凹厚度(CRT),眼底症状积分,血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6),中医症候积分和眼压.结果 (1)眼科指标:治疗前后比较,4组治疗后BCVA均较治疗前改善,MS均较治疗前提高,CRT均较治疗前降低,B组、C组和D组治疗后眼底症状积分均较治疗前降低,差异均有统计学意义(P<0.05).治疗后4组间BCVA、MS、眼底症状积分比较,差异均有统计学意义(P<0.05),D组BCVA、MS、眼底症状积分均优于A组、B组和C组,B组、C组和D组眼底症状积分均低于A组,差异均有统计学意义(P<0.05).治疗后4组间CRT比较,差异无统计学意义(P>0.05).(2)血清指标:治疗前后比较,4组治疗后TC、LDL-C、TNF-α、IL-6均较治疗前降低,差异均有统计学意义(P<0.05).治疗后4组间TC、LDL-C、TNF-α、IL-6比较,差异均有统计学意义(P<0.05).D组治疗后TC、IL-6、TNF-α均低于A组、B组和C组,D组治疗后LDL-C低于A组和B组,差异均有统计学意义(P<0.05).(3)中医症候积分:治疗前后比较,B组、C组和D组治疗后中医症候积分均较治疗前降低,差异均有统计学意义(P<0.05).治疗后4组间比较,差异有统计学意义(P<0.05),B组、C组及D组中医症候积分均低于A组,C组和D组中医症候积分均低于B组,D组中医症候积分低于C组,差异均有统计学意义(P<0.05).(4)不良反应:4组不良反应发生率比较,差异无统计学意义(P>0.05).结论 韦氏三联九针联合益气明目汤治疗高原地区NPDR气阴两虚证,可有效提高患者BCVA和视网膜光敏感度、减轻黄斑水肿、改善眼底损伤,其临床疗效优于单纯西药、单纯针刺或单纯中药治疗.
OBJECTIVE To observe the clinical efficacy of WEI's Triple Nine Needles combined with Chinese medicines in the treatment of non-proliferative diabetic retinopathy(NPDR)in the plateau area.METHODS A total of 120 NPDR patients(120 eyes)diagnosed and treated in Qinghai Provincial Hospital of Traditional Chinese Medicine(TCM)from September 2023 to September 2024,who were differentiated as Qi-Yin deficiency syndrome in TCM,were enrolled in this study.The patients were randomly divided into four groups,with the right eye included in the study for each patient:Western medicine group(Group A),acupuncture group(Group B),TCM group(Group C),and acupuncture combined with TCM group(Group D).Finally,27 cases(27 eyes)were included in Group A,24 cases(24 eyes)in Group B,30 cases(30 eyes)in Group C,and 23 cases(23 eyes)in Group D.Group A was treated with oral calcium dobesilate capsules alone.On the basis of Group A's treatment,Group B was supplemented with WEI's Triple Nine Needles,Group C with oral Yiqi Mingmu Decoction,and Group D with the combination of WEI's Triple Nine Needles and oral Yiqi Mingmu Decoction.All four groups received continuous treatment for 12 weeks.Before and after treatment,the following indices were detected:Best corrected visual acuity(BCVA),mean visual field sensitivity(MS),central retinal thickness(CRT)of the macula,fundus symptom score,total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),TCM syndrome score,and intraocular pressure(IOP).RESULTS(1)Ophthalmic indicators:Comparison before and after treatment showed that BCVA improved,MS increased,and CRT decreased in all four groups after treatment compared to before treatment,the fundus symptom scores in groups B,C and D decreased after treatment compared to before treatment,the differences were all statistically significant(P<0.05).After treatment,comparisons among the four groups showed statistically significant differences in BCVA,MS,and fundus symptom scores(P<0.05).The BCVA,MS,and fundus symptom scores in group D were superior to those in groups A,B,and C,the fundus symptom scores in groups B,C,and D were lower than those in group A,the differences were all statistically significant(P<0.05).After treatment,comparison of CRT among the four groups showed no statistically significant difference(P>0.05).(2)Serum indicators:Comparison before and after treatment showed that TC,LDL-C,TNF-α,and IL-6 decreased in all four groups after treatment compared to before treatment,the differences were all statistically significant(all P<0.05).After treatment,comparisons among the four groups showed statistically significant differences in TC,LDL-C,TNF-α,and IL-6(P<0.05).After treatment,TC,IL-6,and TNF-α in group D were lower than those in groups A,B and C,and LDL-C in group D was lower than that in groups A and B,the differences were all statistically significant(all P<0.05).(3)TCM syndrome scores:Comparison before and after treatment showed that the TCM syndrome scores in groups B,C,and D decreased after treatment compared to before treatment,the differences were all statistically significant(all P<0.05).After treatment,the comparison among the four groups showed a statistically significant difference(P<0.05),the TCM syndrome scores in groups B,C,and D were lower than those in group A,those in groups C and D were lower than those in group B,that in group D was lower than those in group C,the differences were all statistically significant(all P<0.05).(4)Adverse reactions:Comparison of the incidence of adverse reactions among the four groups showed no statistically significant difference(P>0.05).CONCLUSIONS WEI's Triple Nine Needles combined with Yiqi Mingmu Decoction for treating NPDR with Qi-Yin deficiency syndrome in plateau areas can effectively improve patients'BCVA and retinal light sensitivity,reduce macular edema,meliorate fundus damage in NPDR patients with Qi-Yin deficiency syndrome in the plateau area.Its clinical efficacy is superior to that of single Western medicine,single acupuncture,or single TCM treatment.
刘海萍;李晴;安增军;赵守义;朱明娟
青海省中医院,西宁 810099天津中医药大学第一附属医院,天津 300110青海省中医院,西宁 810099青海省中医院,西宁 810099青海省中医院,西宁 810099
医药卫生
韦氏三联九针益气明目汤高原非增殖性糖尿病视网膜病变
WEI's Triple Nine NeedlesYiqi Mingmu Decoctionplateaunon-proliferative diabetic retinopathy
《中国中医眼科杂志》 2026 (8)
724-731,8
1青海省中医院青苗计划(QHSZYY-QM-202304)2青海省中医院院内科研项目(2023YN05)
评论